A Retrospective study to identify the possible Biomarkers of response to Apatinib in patients with advanced Solid tumours
Latest Information Update: 20 Jun 2018
At a glance
- Drugs Rivoceranib (Primary)
- Indications Solid tumours
- Focus Biomarker; Pharmacodynamics; Pharmacogenomic; Therapeutic Use
- 20 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology